M
Michelle Alexander
Researcher at University of Connecticut
Publications - 12
Citations - 372
Michelle Alexander is an academic researcher from University of Connecticut. The author has contributed to research in topics: Erythropoietin & Spatial memory. The author has an hindex of 8, co-authored 12 publications receiving 326 citations. Previous affiliations of Michelle Alexander include University of Minnesota.
Papers
More filters
Journal ArticleDOI
Sex differences in behavioral outcome following neonatal hypoxia ischemia: Insights from a clinical meta-analysis and a rodent model of induced hypoxic ischemic brain injury
TL;DR: In this article, the authors examined published clinical studies from the past 20 years where long-term IQ outcome scores for matched groups of male and female premature infants were reported separately (IQ being the most common outcome measure).
Journal ArticleDOI
Behavioral and histological outcomes following neonatal HI injury in a preterm (P3) and term (P7) rodent model.
TL;DR: Behavioral deficits following neonatal HI are task-specific depending on timing of injury; the more pervasive behavioral deficits seen following P7 HI injury were associated with substantial global tissue loss; and persistent deficits in attention in P3 HI subjects might be linked to neural connectivity disturbances rather than a global loss of brain volume.
Journal ArticleDOI
Inhibition of X-linked inhibitor of apoptosis with embelin differentially affects male versus female behavioral outcome following neonatal hypoxia-ischemia in rats.
TL;DR: Results support sex differences in mechanisms of cell death following early HI injuries, and suggest a potential clinical benefit from the development of sex-specific neuroprotectants for the treatment of HI.
Journal ArticleDOI
Therapeutic Effect of Caffeine Treatment Immediately Following Neonatal Hypoxic-Ischemic Injury on Spatial Memory in Male Rats
TL;DR: Investigating the therapeutic benefit of caffeine following early HI injury in male rats suggests that caffeine is a potential therapeutic agent that could be used in HI injured infants to reduce brain injury and preserve subsequent cognitive function.
Journal ArticleDOI
Evaluation of the Therapeutic Benefit of Delayed Administration of Erythropoietin following Early Hypoxic-Ischemic Injury in Rodents
TL;DR: The current data show that the effectiveness of a single dose of Epo in ameliorating auditory processing deficits following HI injury decreases precipitously as treatment is delayed following injury, which may have important implications for experimental human neonatal intervention with Epo.